Ocumont Eye Ointment 1% w/w
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 4 defect notification · DMRC-38025137
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Ocumont Eye Ointment 1% w/w | PL: 31103/0018 | chloramphenicol | 5060148680286 |
Batches (expiry): B0866 (30/11/2028)
Background: Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of the above-mentioned batch of OCUMONT Eye Ointment 1% w/w (POM). It was identified that the Braille information was inadvertently omitted during the approval and release process. This issue is limited to a single batch (Lot B0866) that has been distributed. The quality of the ointment is not affected by this defect. All other batches distributed contain the Braille information on the outer carton. Advice for Healthcare Professionals:
